Key facts
- This page summarizes Tomer Ben-Kiki's Form 4 filing for DarioHealth Corp. (DRIO).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 21 Feb 2024, 16:16.
Tomer Ben-Kiki - 15 Feb 2024 Form 4 Insider Report for DarioHealth Corp. (DRIO)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- DRIO
- Reported as of
- 15 Feb 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ Tomer Ben-Kiki
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Tomer Ben-Kiki filed Form 4 for DarioHealth Corp. (DRIO) on 21 Feb 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DRIO
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +717,947
- Change %
- Price
- $0.000000
- Shares after
- 717,947
- Date
- 15 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 717,947
- Exercise price
- $2.55
- Footnotes
- F1
DRIO
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +300,000
- Change %
- Price
- $0.000000
- Shares after
- 300,000
- Date
- 15 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 300,000
- Exercise price
- $2.55
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The options vest as follows: 291,742 shares vest immediately, and the remaining 426,205 shares vest over two years in eight equal quarterly amounts, subject to subject to the Reporting Person's continued services to the Issuer on the applicable vesting date.
Footnote F2
The options vest immediately upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principals basis) for the year ending December 31, 2024, the achievement of certain operating expense targets for the years ending December 31, 2024 and December 31, 2025, the ability to generate software value from funds invested and meet product roadmap and the retention of key employees post transaction, subject in each case to the Reporting Person's continued services to the Issuer on the applicable vesting date.